Sanofi has said its radioligand therapy (RLT) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) hit all its objectives in a phase 2 study, setting up possible regulatory filings. The ...
It’s the only way to make sound trade-off decisions and choose the right practices. by Gary P. Pisano Despite massive investments of management time and money, innovation remains a frustrating pursuit ...
MSI Stealth 14 AI Studio A1VFG-053IN Gaming Laptop (Intel Core Ultra 7 155H/ 16GB/ 1TB SSD/ Win11 Home/ 8GB RTX 4060 Graph) ₹ 1,42,107 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback